| 标题 |
[求助补充材料]
 Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial |
| 网址 | |
| DOI | |
| 其它 |
期刊：Lancet Oncology 作者：Chiara Cremolini; Carlotta Antoniotti; Daniele Rossini; Sara Lonardi; Fotios Loupakis; et al 出版日期：2020-03-09 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时，文件已从服务器自动删除，无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Nole
cdercder
东方元语
张欢馨
OK
呵呵
aajhajkahna
xing_xing
MozzieMiao
昏睡的蟠桃
丰富语蕊
Kao
yi
可爱的小paper
cat
v0id
初景
yjh123
Nexus
七听
皖公网安备34019202002308
